According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is €0.20 Billion. In 2021 the company made a revenue of €0.17 Billion an increase over the revenue in the year 2020 that were of €67.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.